SYSNORM

Systems Networks Norms

 Coordinatore ACADEMISCH ZIEKENHUIS GRONINGEN 

 Organization address address: Hanzeplein 1
city: GRONINGEN
postcode: 9713 GZ

contact info
Titolo: Prof.
Nome: Cisca
Cognome: Wijmenga
Email: send email
Telefono: +31 50 361 7245
Fax: +31 50 361 7245

 Nazionalità Coordinatore Netherlands [NL]
 Totale costo 354˙111 €
 EC contributo 354˙111 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2011-IOF
 Funding Scheme MC-IOF
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-01-01   -   2015-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    ACADEMISCH ZIEKENHUIS GRONINGEN

 Organization address address: Hanzeplein 1
city: GRONINGEN
postcode: 9713 GZ

contact info
Titolo: Prof.
Nome: Cisca
Cognome: Wijmenga
Email: send email
Telefono: +31 50 361 7245
Fax: +31 50 361 7245

NL (GRONINGEN) coordinator 123˙599.90
2    STICHTING VU-VUMC

 Organization address address: DE BOELELAAN 1105
city: AMSTERDAM
postcode: 1081 HV

contact info
Titolo: Dr.
Nome: Yvonne
Cognome: Kops
Email: send email
Telefono: +31 20 598 7400

NL (AMSTERDAM) participant 230˙511.80
3    VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG

 Organization address address: De Boelelaan 1105
city: AMSTERDAM
postcode: 1081 HV

contact info
Titolo: Prof.
Nome: Hans V.
Cognome: Westerhoff
Email: send email
Telefono: 31205987230
Fax: 31205987229

NL (AMSTERDAM) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

data    genome    genomic    normative    editing    unprecedented    sysnorm    blueprint    examples    ethics    theory    medicine    foundational    levels    scientific    network    medical    disease    sciences    norms    training    first    humanities    human    innovative    advancements    ethical    health    breakthrough    science    replacing    generation    biology    genetic    networks    basic    philosophy    implications    harvard    model    technologies   

 Obiettivo del progetto (Objective)

'Genomic sciences are driving progress in biology at an unprecedented pace, most recently through third-generation sequencing and synthetic biology. These achievements challenge commonly accepted biological concepts and assumptions in the humanities. In this Fellowship I will investigate the impact of genomic sciences on theory development in the social and human sciences, with focus on philosophy and ethics, and develop innovative normative models that align with this new knowledge. Harvard University will provide a unique setting for this investigation through its juxtaposition of front line genomics and medical research with rich humanities resources. My hypothesis is that systems approaches in biology are replacing traditional ontologies of health and disease - based on compendia of symptoms and test reference ranges - with emergent states and activity levels of nonlinear genetic networks. These concepts will induce substantial changes in objectives of basic research, translation of this research into practice, and, ultimately, the delivery and prioritization of health services. This shift must be assimilated into the philosophy and ethics that appraise these activities. Research and training at the Church lab at Harvard Medical School, a Center of Excellence in Genomic Science, will propel my academic career and bring innovative knowledge to Europe. The plan will be to work hands-on with genomic scientists to identify and develop specific examples of pathway characterizations that are in the process of replacing current health and disease categories, extrapolate how these foundational changes will translate into basic research and health care practices, and use the network examples to develop a blueprint for a systems biology-relevant normative model. Specific training objectives are framed in the proposal for human systems biology, network theory and analysis tools, medical genetics and ethics, and in the practice of professional scientific leadership.'

Introduzione (Teaser)

EU funding is enabling researchers to determine ethical norms for newly emerging scientific disciplines such as genomic science and network medicine.

Descrizione progetto (Article)

Scientific advancements in biomedicine have reached unprecedented levels, and application of genome editing in clinical practice is far from far-fetched. Genome editing refers to breakthrough technology that can alter the genetic sequence of entire animal or plant populations that can be passed to the next generation. Under the aegis of the project SYSNORM (Systems networks norms), researchers studied the implications of systems biology and network medicine on health and disease.

In the first year of the project, researchers developed a novel foundational argument for dealing with comprehensive human data sets generated from high-throughput genome analyses. SYSNORM also worked on assessing the ethical implications of cutting-edge technologies such as organ-on-chip and organoid model systems.

A key area of focus was on genome editing through CRISPR-Cas9 technology. SYSNORM obtained novel insight into the ethical and regulatory aspects of breakthrough 'gene drive' technology that permits real-time genome editing.

The first two years of the project led to eight publications in major journals and more are on the way. Training activities included participation in meetings, seminars, conferences and workshops and the development of courses.

Overall, SYSNORM activities are contributing to the development of a blueprint for a systems biology-relevant normative model for genomic technologies. In the current scenario of rapid technological advancements, this project has addressed several issues of societal relevance, including data sharing and ethics.

Altri progetti dello stesso programma (FP7-PEOPLE)

SITELITE (2012)

"Deterministic coupling between SITE-controlled, dilute nitride-based LighT Emitters and tailor-made photonic-crystal structures"

Read More  

ADVENTITIA (2008)

The arterial adventitia: a critical actor in atherosclerotic plaque progression and stability?

Read More  

X-MIAM (2010)

X-ray Multiple Ionization of Impulsively Aligned Molecules

Read More